COVID variables in R&D	Number of employees	Total
Number of enterprises that carry out intramural R&D	Less than 10 employees	2,752
Number of enterprises that carry out intramural R&D	From 10 to 49 employees	4,509
Number of enterprises that carry out intramural R&D	From 50 to 249 employees	2,862
Number of enterprises that carry out intramural R&D	250 and more employees	1,065
Number of enterprises that carry out intramural R&D	Total	11,188
% of companies whose internal R&D expenditure was increased by COVID-19	Less than 10 employees	7.98
% of companies whose internal R&D expenditure was increased by COVID-19	From 10 to 49 employees	7.31
% of companies whose internal R&D expenditure was increased by COVID-19	From 50 to 249 employees	5.51
% of companies whose internal R&D expenditure was increased by COVID-19	250 and more employees	5.67
% of companies whose internal R&D expenditure was increased by COVID-19	Total	6.86
% of companies whose internal R&D expenditure was decreased by COVID-19	Less than 10 employees	30.45
% of companies whose internal R&D expenditure was decreased by COVID-19	From 10 to 49 employees	27.20
% of companies whose internal R&D expenditure was decreased by COVID-19	From 50 to 249 employees	26.20
% of companies whose internal R&D expenditure was decreased by COVID-19	250 and more employees	29.33
% of companies whose internal R&D expenditure was decreased by COVID-19	Total	27.95
% of companies that performed internal R&D related to COVID-19	Less than 10 employees	7.96
% of companies that performed internal R&D related to COVID-19	From 10 to 49 employees	8.25
% of companies that performed internal R&D related to COVID-19	From 50 to 249 employees	8.25
% of companies that performed internal R&D related to COVID-19	250 and more employees	11.01
% of companies that performed internal R&D related to COVID-19	Total	8.44
Total expenditure on internal R&D related to COVID-19	Less than 10 employees	8,106
Total expenditure on internal R&D related to COVID-19	From 10 to 49 employees	23,155
Total expenditure on internal R&D related to COVID-19	From 50 to 249 employees	39,162
Total expenditure on internal R&D related to COVID-19	250 and more employees	58,852
Total expenditure on internal R&D related to COVID-19	Total	129,275